{
    "organizations": [],
    "uuid": "93e9945370b7afe4548983f2be5668e3a8955f62",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cadila-healthcare-says-zydus-gets/brief-cadila-healthcare-says-zydus-gets-u-s-fda-nod-for-metoprolol-succinate-extended-release-tablets-usp-idUSFWN1R700Q",
    "ord_in_thread": 0,
    "title": "BRIEF-Cadila Healthcare Says ‍Zydus Gets U.S. FDA Nod For Metoprolol Succinate Extended-Release Tablets USP​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 26 (Reuters) - Cadila Healthcare Ltd:\n* SAYS ‍ZYDUS RECEIVES FINAL APPROVAL FROM USFDA FOR METOPROLOL SUCCINATE EXTENDED-RELEASE TABLETS USP​ Source text - bit.ly/2pEyVGd Further company coverage:\n ",
    "published": "2018-03-26T11:21:00.000+03:00",
    "crawled": "2018-03-26T14:22:37.012+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "cadila",
        "healthcare",
        "ltd",
        "say",
        "receives",
        "final",
        "approval",
        "usfda",
        "metoprolol",
        "succinate",
        "tablet",
        "source",
        "text",
        "company",
        "coverage"
    ]
}